BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30756461)

  • 1. Extracapsular invasion: A potential prognostic marker for Carcinoma ex-pleomorphic adenoma of the salivary glands? A Systematic Review.
    de Morais EF; Pinheiro JC; Sena DAC; Galvão HC; de Souza LB; de Almeida Freitas R
    J Oral Pathol Med; 2019 Jul; 48(6):433-440. PubMed ID: 30756461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Carcinoma ex pleomorphic adenoma of major salivary glands--a clinicopathologic review].
    Stodulski D; Rzepko R; Kowalska B; Stankiewicz C
    Otolaryngol Pol; 2007; 61(5):687-93. PubMed ID: 18552001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases.
    Katabi N; Gomez D; Klimstra DS; Carlson DL; Lee N; Ghossein R
    Hum Pathol; 2010 Jul; 41(7):927-34. PubMed ID: 20338616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of prognostic factors in carcinoma ex pleomorphic adenoma.
    Key S; Chia C; Hasan Z; Sundaresan P; Dwivedi RC; Riffat F
    Oral Oncol; 2022 Oct; 133():106052. PubMed ID: 35921695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pleomorphic adenoma: pitfalls and clinicopathological forms of progression].
    Ihrler S; Schwarz S; Zengel P; Guntinas-Lichius O; Kirchner T; Weiler C
    Pathologe; 2009 Nov; 30(6):446-56. PubMed ID: 19844715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors affecting the clinical outcome of carcinoma ex pleomorphic adenoma in the major salivary gland.
    Zhao J; Wang J; Yu C; Guo L; Wang K; Liang Z; Lou J
    World J Surg Oncol; 2013 Aug; 11(1):180. PubMed ID: 23924064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
    Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma.
    Griffith CC; Thompson LD; Assaad A; Purgina BM; Lai C; Bauman JE; Weinreb I; Seethala RR; Chiosea SI
    Histopathology; 2014 Dec; 65(6):854-60. PubMed ID: 24804831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma ex pleomorphic adenoma of the upper lip.
    Dyalram D; Huebner T; Papadimitriou JC; Lubek J
    Int J Oral Maxillofac Surg; 2012 Mar; 41(3):364-7. PubMed ID: 22209228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome.
    Sedassari BT; Rodrigues MFSD; Conceição TS; Mariano FV; Alves VAF; Nunes FD; Altemani A; de Sousa SCOM
    Virchows Arch; 2017 Dec; 471(6):775-784. PubMed ID: 28842747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
    de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
    Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study.
    Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Nishiyama K; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
    Histopathology; 2012 May; 60(6B):E131-42. PubMed ID: 22486195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma ex-pleomorphic adenoma of the salivary glands has a high risk of progression when the tumor invades more than 2.5 mm beyond the capsule of the residual pleomorphic adenoma.
    Rito M; Fonseca I
    Virchows Arch; 2016 Mar; 468(3):297-303. PubMed ID: 26638158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.
    Soares AB; Ponchio L; Juliano PB; de Araújo VC; Altemani A
    J Clin Pathol; 2007 Sep; 60(9):995-1000. PubMed ID: 17079351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma ex pleomorphic adenoma of the minor salivary gland with pulmonary metastasis.
    Akan H; Yildiz L; Unal R
    Diagn Interv Radiol; 2008 Mar; 14(1):3-5. PubMed ID: 18306136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
    Lewis JE; Olsen KD; Sebo TJ
    Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoma ex pleomorphic adenoma with special reference to the prognostic significance of histological progression: a clinicopathological investigation of 41 cases.
    Weiler C; Zengel P; van der Wal JE; Guntinas-Lichius O; Schwarz S; Harrison JD; Kirchner T; Ihrler S
    Histopathology; 2011 Oct; 59(4):741-50. PubMed ID: 22014054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Proliferation Index between Carcinoma Ex-Pleomorphic Adenoma and Pleomorphic Adenoma.
    Mariano FV; Costa AF; Gondak RO; Martins AS; Del Negro A; Tincani ÁJ; Altemani A; de Almeida OP; Kowalski LP
    Braz Dent J; 2015; 26(4):416-21. PubMed ID: 26312983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma Ex Pleomorphic Adenoma: Is It a High-Grade Malignancy?
    Ye P; Gao Y; Mao C; Guo CB; Yu GY; Peng X
    J Oral Maxillofac Surg; 2016 Oct; 74(10):2093-104. PubMed ID: 27131030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
    Key S; Chia C; Hasan Z; Sundaresan P; Riffat F; Dwivedi RC
    Laryngoscope; 2024 Mar; 134(3):1042-1053. PubMed ID: 37610148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.